The Drug Controller General of India (DCGI) prohibited the importation of APIs from 10 China companies because the companies had not submitted good manufacturing practices (GMP) certificates. India’s only external API suppliers are located in China. The products involved in the ban are used to make anti-infectives and painkillers. More details...